Search
Now showing items 1-6 of 6
The prognostic value of UHRF-1 and p53 in gastric cancer
(MEDKNOW PUBLICATIONS & MEDIA PVT LTD, 2016)
Background/Aims: This study aimed to examine whether UHRF-1 and p53 overexpression is a prognostic marker for gastric cancer. Patients and Methods: Sixty-four patients with gastric cancer (study group) and 23 patients with ...
Higher Ki67 Expression is Associates With Unfavorable Prognostic Factors and Shorter Survival in Breast Cancer
(ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)
Background: The prognostic value of the Ki67 expression level is yet unclear in breast cancer. The aim of this study was to investigate the association between Ki67 expression levels and prognostic factors such as grade, ...
Clinicopathologic Features of Gastric Cancer in Young Patients
(MEDKNOW PUBLICATIONS & MEDIA PVT LTD, 2013)
Background/Aim: Gastric cancer (GC) is considered to be a disease of elderly patients. It has been suggested that GC in young adults has more aggressive clinical and pathologic features than in adults. In this study we ...
Recurrence Risk and Prognostic Parameters in Stage I Rectal Cancers
(ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)
Background: The standard therapy for stage I rectum cancer is surgical resection. Currently, there is no strong evidence to suggest that any type of adjuvant therapy is beneficial. The risks of local relapse and distant ...
Treatment and Outcomes of Ewing Sarcoma in Turkish Adults: A Single Centre Experience
(ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)
Background: Ewing sarcoma is a small round cell tumor arising from soft tissue and bone that predominantly affects children and adolescents. The most unfavorable prognostic factor is the presence of distant metastasis at ...
Clinicopathologic Features and Prognosis of Osteosarcoma in Turkish Adults
(ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)
Background: Osteosarcomas are the most common solid malignancies of bone. In the last two decades there have been no concrete developments in their systemic treatment. In this trial we aimed to present our osteosarcoma ...